ObesityPhase 4NCT01556061
Comparison of Storz C-MAC and D-MAC Orotracheal Intubation Systems in Morbidly Obese Patients
A Phase 4 study testing DMAC and CMAC in people with Obesity, run by The University of Texas Health Science Center, Houston at 1 site in United States.
Trial summary
The investigators hypothesize that the D-MAC (Dblade with C-MAC system) may be a suitable alternative device for difficult laryngoscopy and tracheal intubation in morbidly obese patients. The D-MAC will enable superior view of the glottic structures as well as easier endotracheal intubations than the C-MAC blade. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Obesity
- What is being tested?
- DMAC and CMAC
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteUnited States
- Study dates
- Jun 2011to Dec 2011
- Phase
- Phase 4
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age 18-65 years
- ASA I-III
- BMI ≥ 40 kg/m2
Who cannot join
- Necessary awake intubation
- Mallampati IV
- < 2 finger breath or 4 cm mouth opening
- Previous history of difficult intubation
- ASA IV-V
- Unstable cervical, thoracic and/or lumbar fracture
- Known history of congestive heart failure or a severe disease that alters pulmonary mechanics (e.g. chronic obstructive pulmonary disease, restrictive lung diseases)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Comparison of Storz C-MAC and D-MAC Orotracheal Intubation Systems in Morbidly Obese Patients - A Prospective Randomized Crossover Trial
The investigators hypothesize that the D-MAC (Dblade with C-MAC system) may be a suitable alternative device for difficult laryngoscopy and tracheal intubation in morbidly obese patients. The D-MAC will enable superior view of the glottic structures as well as easier endotracheal intubations than the C-MAC blade. This is the first study to investigate the individual and comparative performances of C-MAC and D-MAC in this patient cohort.
Read the detailed description
Since the introduction of laryngoscopy, blades have undergone design innovations with the goal of improving laryngeal visualization and successful tracheal intubation because difficult intubation may be encountered even in patients with favorable anatomy.
Failed intubation shows occurrence in 0.05% of surgical patients and in 0.13% to 0.35% of obstetric and obese patients and the incidence of unsuspected difficult intubation is estimated to be higher at approximately 3%, with poor airway visualization being a major contributing factor.
Moreover airway management in the obese patient population requires special consideration. An increased BMI is associated with reduced posterior airway space and improper mask ventilation, both of which may lead to rapid development of hypoxemia and possible desaturation immediately after anesthetic induction.
As the prevalence of obesity has increased from 23% in 1992 to 33.8% in 2008 and an estimated 140,000 surgical bariatric cases are performed in the U.S., anesthesiologists face challenges of airway management in this population.
The main advantage of video intubation is provision of superior views compared to traditional laryngoscopy.
This study is designed to determine preliminarily the efficacy of the the D-BLADE [D-MAC] intubation systems compared to C-MAC in the bariatric population. The hypothesis is that D-MAC will enable superior view of the glottic structures as well as easier endotracheal intubations than the C-MAC blade.
- General Study Design- The study will include a total of 50 morbidly obese patients (BMI ≥ 40kg/m2) scheduled for elective surgery (bariatric, gynecological, urological, general abdominal and otorhinolaryngology) at Memorial Hermann Hospital.
All patients will be intubated using conventional endotracheal tubes and preferably without any alternative aid to intubation. Patient will be followed for the time they will spend in the operating block (from the airway assessment time to the time of PACU discharge).
In the operating room, ASA standard monitoring devices will be applied: a pulse oximeter, a 3 lead ECG, and a blood pressure cuff (or invasive blood pressure depending on the patients' conditions). Pre-induction baseline measurements of blood pressure, heart rate, percent oxygen saturation and end tidal CO2 will be made. Patients will be positioned in a head elevated position (RAMP or TROOP pillow) and pre-oxygenated for 5 minutes. One set of pre-insertion vital signs (after induction) will be obtained. From the time anesthetic induction is begun until five minutes after the patient has been successfully intubated, five sets of vital signs will be recorded at one minute intervals. General anesthesia will be induced by bolus administration of propofol (2-3 mg/kg), fentanyl (2 mcg/kg), and succinylcholine (1mg/kg) per ideal body weight (assuming an ideal BMI of 32 kg/m2 up to a BMI of 50 kg/m2 and an ideal BMI 35 kg/m2 over 50 kg/m2. A rapid sequence induction (RSI) will be performed. RSI will be achieved with suxamethonium.The lungs will be mechanically ventilated with a semi-closed circle system to maintain an end-tidal CO2 near 35 mmHg. Patients' lungs will be ventilated via face-mask for 3 minutes with 100% oxygen until the patient is completely relaxed.
A ll investigators (residents and attending) will be trained based on manufacturer recommendations, and each resident will perform at least 3 intubations with the C-MAC and D-MAC video laryngoscope prior to enlisting any patients for the study. Intubations will be performed by 2nd and 3rd year (CA-2 and CA-3) residents. Size 3 blades of CMAC will be utilized in all cases (a size 4 will be available if necessary).
A computer-generated list will randomize the order of C-MAC and D-MAC to prevent bias. The resident will use either the C-MAC first followed by the D-MAC, or viceversa, and will declare the Cormack-Lehane Scale score for each method. Intubation will be attempted after the second laryngoscopy technique being used. External neck pressure may be applied by an assistant to improve laryngeal exposure. Any external manipulation will be recorded, and the optimal view obtained and the time required to obtain it for each method will be recorded.
The resident will have only one attempt each for C-MAC and D-MAC laryngoscopy. If the first attempt is unsuccessful, the attending anesthesiologist will take one more attempt for that particular method, C-MAC or D-MAC. The number of attempts (maximum 4 total as defined by reinsertion of either the blade or endotracheal tube), time required to obtain optimum view, CL score of view, and time required to intubate will all be recorded. Intubation time is defined by time from which the anesthesiologist has ETT in hand to when the ETT cuff passes distally through vocal cords. If unsuccessful, the direct laryngoscopy/flexible fiberoptic laryngoscopy will be performed to intubate the trachea. If more than 4 attempts are needed, or if the anesthesiologist discontinues use of the video laryngoscope, the case will be considered a failure. The resident's subjective opinion on laryngoscopy and intubation difficulty level (from 1 = Extremely Easy, to 5 = Extremely Difficult) will also be recorded.
In order to maintain patient safety all intubation attempts will be performed within the safety apnea time or time for oxygen blood saturation to drop to 92%.
- Measurements Pre-operatively, morphometric characteristics of all patients will be recorded: Mallampati score, adequacy of neck mobility, neck circumference, thyromental distance, sternomental distance, and interincisor gap distance.
Degree of irritation: Following intubation in either group, the appearance of oropharynx, pharynx, epiglottis, and arytenoids will be checked. The presence of abrasions, bleeding, redness, perforation or other signs of tissue or dental injury will be recorded. Also, the patient's subjective report of soreness, hoarseness, or dysphagia post-operatively will be recorded as well.
DATA ANALYSIS:
This investigation will serve as preliminary study to determine if there is an improved rate of airway view during C-MAC or D-MAC video laryngoscopy. The study will have a time frame of 12 months. Data will be summarized using mean ± SD, median and interquantile, and frequency (%) for discrete variables by each group. Appropriate tests like t-test, ANOVA, chi-squared, and Fischer tests will be used to compare the mean primary outcome variable, duration of desaturation, between two groups after adjusting the effects of risk factors.
For the secondary outcome variables, appropriate tests like t-test, ANOVA, or the chi-squared tests will be performed to compare the continuous variables between two groups to compare the percentage of discrete outcome variables between two groups.
Statistical analyses will be conducted using STATA 10.0 College Station, TX and a p-value < 0.05 will be considered as statistical significant.
- Conditions
- Obesity
- Being tested
- DMAC, CMAC
- Keywords
- Laryngoscopy, Airway Management, Intubation
- Medical subject headings
- Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DMACDevice
Also called D-Blade CMAC system
The D blade will constitute the experimental treatment and in a cross over fashion will be tested against CMAC blade
CMACDevice
Also called CMAC blade
The CMAC Blade will constitute the active comparator treatment and in a cross over fashion will be tested against D-blade
| Study group | Role | What they receive |
|---|---|---|
| D-MAC video laryngoscopy | Experimental | The Dblade is used to perfom laryngoscopy first but second laryngoscopy and intubation is performed with CMAC blade. Receives: Device: DMAC; Device: CMAC |
| C-MAC video laryngoscopy | Active comparator | The CMAC blade is used to perfom laryngoscopy first but second laryngoscopy and intubation is performed with D-blade Receives: Device: DMAC; Device: CMAC |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time for Intubation
Time taken for successful placement of endotracheal tube after a successful laryngoscopy. Typically a successful laryngoscopy will range from few seconds to no more than 90 seconds. A successful intubation will not range more than 90 seconds.
Measured: 90 seconds
Secondary outcomes (2)
First Laryngoscopy
Patients underwent laryngoscopy first with their assigned randomized laryngoscope. Time measured was from the time from the moment the anesthesiologist had the laryngoscope in hand to time to optimal visualization of vocal cords.
Measured: 30 seconds
Second Laryngoscopy
A second laryngoscopy will be performed in patients with the video laryngoscope from the other group. Patients will be intubated after second laryngoscopy with with this same video laryngoscope.
Measured: 30 seconds
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Mar 2012 (estimated)
- Study startJun 2011
- Primary completionDec 2011
- Study completionDec 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for ObesityStudies of the same condition, open and under way.
- More trials run by The University of Texas Health Science Center, HoustonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Davide Cattano, The University of Texas Health Science Center, Houston
- Investigators
- Davide Cattano, MD, PhD, Principal investigator, University Of Texas at Houston Medical School
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01556061
- Sponsor's protocol ID
- HSC-MS-10-0573
- Status last verified
- Apr 2014
- First submitted
- 1 Mar 2012
- Last updated
- 26 May 2014
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 26 May 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Storz C-MAC and D-MAC Orotracheal Intubation Systems in Morbidly Obese Patients - A Prospective Randomized Crossover Trial
- ClinicalTrials.gov ID
- NCT01556061
- Acronym / sponsor ID
- HSC-MS-10-0573
- Conditions
- Obesity
- Keywords
- Laryngoscopy, Airway Management, Intubation
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- The University of Texas Health Science Center, HoustonUniversity, hospital or other
- Study start
- Jun 2011
- Primary completion
- Dec 2011 (actual)
- Study completion
- Dec 2011 (actual)
- First posted
- 16 Mar 2012 (estimated)
- Results
- Posted 26 May 2014
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators hypothesize that the D-MAC (Dblade with C-MAC system) may be a suitable alternative device for difficult laryngoscopy and tracheal intubation in morbidly obese patients. The D-MAC will enable superior view of the glottic structures as well as easier endotracheal intubations than the C-MAC blade. This is the first study to investigate the individual and comparative performances of C-MAC and D-MAC in this patient cohort.
Detailed description
Since the introduction of laryngoscopy, blades have undergone design innovations with the goal of improving laryngeal visualization and successful tracheal intubation because difficult intubation may be encountered even in patients with favorable anatomy.
Failed intubation shows occurrence in 0.05% of surgical patients and in 0.13% to 0.35% of obstetric and obese patients and the incidence of unsuspected difficult intubation is estimated to be higher at approximately 3%, with poor airway visualization being a major contributing factor.
Moreover airway management in the obese patient population requires special consideration. An increased BMI is associated with reduced posterior airway space and improper mask ventilation, both of which may lead to rapid development of hypoxemia and possible desaturation immediately after anesthetic induction.
As the prevalence of obesity has increased from 23% in 1992 to 33.8% in 2008 and an estimated 140,000 surgical bariatric cases are performed in the U.S., anesthesiologists face challenges of airway management in this population.
The main advantage of video intubation is provision of superior views compared to traditional laryngoscopy.
This study is designed to determine preliminarily the efficacy of the the D-BLADE [D-MAC] intubation systems compared to C-MAC in the bariatric population. The hypothesis is that D-MAC will enable superior view of the glottic structures as well as easier endotracheal intubations than the C-MAC blade.
- General Study Design- The study will include a total of 50 morbidly obese patients (BMI ≥ 40kg/m2) scheduled for elective surgery (bariatric, gynecological, urological, general abdominal and otorhinolaryngology) at Memorial Hermann Hospital.
All patients will be intubated using conventional endotracheal tubes and preferably without any alternative aid to intubation. Patient will be followed for the time they will spend in the operating block (from the airway assessment time to the time of PACU discharge).
In the operating room, ASA standard monitoring devices will be applied: a pulse oximeter, a 3 lead ECG, and a blood pressure cuff (or invasive blood pressure depending on the patients' conditions). Pre-induction baseline measurements of blood pressure, heart rate, percent oxygen saturation and end tidal CO2 will be made. Patients will be positioned in a head elevated position (RAMP or TROOP pillow) and pre-oxygenated for 5 minutes. One set of pre-insertion vital signs (after induction) will be obtained. From the time anesthetic induction is begun until five minutes after the patient has been successfully intubated, five sets of vital signs will be recorded at one minute intervals. General anesthesia will be induced by bolus administration of propofol (2-3 mg/kg), fentanyl (2 mcg/kg), and succinylcholine (1mg/kg) per ideal body weight (assuming an ideal BMI of 32 kg/m2 up to a BMI of 50 kg/m2 and an ideal BMI 35 kg/m2 over 50 kg/m2. A rapid sequence induction (RSI) will be performed. RSI will be achieved with suxamethonium.The lungs will be mechanically ventilated with a semi-closed circle system to maintain an end-tidal CO2 near 35 mmHg. Patients' lungs will be ventilated via face-mask for 3 minutes with 100% oxygen until the patient is completely relaxed.
A ll investigators (residents and attending) will be trained based on manufacturer recommendations, and each resident will perform at least 3 intubations with the C-MAC and D-MAC video laryngoscope prior to enlisting any patients for the study. Intubations will be performed by 2nd and 3rd year (CA-2 and CA-3) residents. Size 3 blades of CMAC will be utilized in all cases (a size 4 will be available if necessary).
A computer-generated list will randomize the order of C-MAC and D-MAC to prevent bias. The resident will use either the C-MAC first followed by the D-MAC, or viceversa, and will declare the Cormack-Lehane Scale score for each method. Intubation will be attempted after the second laryngoscopy technique being used. External neck pressure may be applied by an assistant to improve laryngeal exposure. Any external manipulation will be recorded, and the optimal view obtained and the time required to obtain it for each method will be recorded.
The resident will have only one attempt each for C-MAC and D-MAC laryngoscopy. If the first attempt is unsuccessful, the attending anesthesiologist will take one more attempt for that particular method, C-MAC or D-MAC. The number of attempts (maximum 4 total as defined by reinsertion of either the blade or endotracheal tube), time required to obtain optimum view, CL score of view, and time required to intubate will all be recorded. Intubation time is defined by time from which the anesthesiologist has ETT in hand to when the ETT cuff passes distally through vocal cords. If unsuccessful, the direct laryngoscopy/flexible fiberoptic laryngoscopy will be performed to intubate the trachea. If more than 4 attempts are needed, or if the anesthesiologist discontinues use of the video laryngoscope, the case will be considered a failure. The resident's subjective opinion on laryngoscopy and intubation difficulty level (from 1 = Extremely Easy, to 5 = Extremely Difficult) will also be recorded.
In order to maintain patient safety all intubation attempts will be performed within the safety apnea time or time for oxygen blood saturation to drop to 92%.
- Measurements Pre-operatively, morphometric characteristics of all patients will be recorded: Mallampati score, adequacy of neck mobility, neck circumference, thyromental distance, sternomental distance, and interincisor gap distance.
Degree of irritation: Following intubation in either group, the appearance of oropharynx, pharynx, epiglottis, and arytenoids will be checked. The presence of abrasions, bleeding, redness, perforation or other signs of tissue or dental injury will be recorded. Also, the patient's subjective report of soreness, hoarseness, or dysphagia post-operatively will be recorded as well.
DATA ANALYSIS:
This investigation will serve as preliminary study to determine if there is an improved rate of airway view during C-MAC or D-MAC video laryngoscopy. The study will have a time frame of 12 months. Data will be summarized using mean ± SD, median and interquantile, and frequency (%) for discrete variables by each group. Appropriate tests like t-test, ANOVA, chi-squared, and Fischer tests will be used to compare the mean primary outcome variable, duration of desaturation, between two groups after adjusting the effects of risk factors.
For the secondary outcome variables, appropriate tests like t-test, ANOVA, or the chi-squared tests will be performed to compare the continuous variables between two groups to compare the percentage of discrete outcome variables between two groups.
Statistical analyses will be conducted using STATA 10.0 College Station, TX and a p-value < 0.05 will be considered as statistical significant.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| D-MAC video laryngoscopy | Experimental | Device: DMAC, Device: CMACThe Dblade is used to perfom laryngoscopy first but second laryngoscopy and intubation is performed with CMAC blade. |
| C-MAC video laryngoscopy | Active comparator | Device: DMAC, Device: CMACThe CMAC blade is used to perfom laryngoscopy first but second laryngoscopy and intubation is performed with D-blade |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Age 18-65 years
- ASA I-III
- BMI ≥ 40 kg/m2
Key exclusion criteria (7 listed)
- Necessary awake intubation
- Mallampati IV
- < 2 finger breath or 4 cm mouth opening
- Previous history of difficult intubation
- ASA IV-V
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DMACAlso: D-Blade CMAC systemThe D blade will constitute the experimental treatment and in a cross over fashion will be tested against CMAC blade | Device | C-MAC video laryngoscopy, D-MAC video laryngoscopy |
| CMACAlso: CMAC bladeThe CMAC Blade will constitute the active comparator treatment and in a cross over fashion will be tested against D-blade | Device | C-MAC video laryngoscopy, D-MAC video laryngoscopy |
Primary outcome
Time for Intubation
Time frame: 90 seconds
Time taken for successful placement of endotracheal tube after a successful laryngoscopy. Typically a successful laryngoscopy will range from few seconds to no more than 90 seconds. A successful intubation will not range more than 90 seconds.
2 secondary outcomes
First Laryngoscopy
Time frame: 30 seconds
Second Laryngoscopy
Time frame: 30 seconds
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 May 2014.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Obesity
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Davide Cattano, MD, PhD principal investigator
University Of Texas at Houston Medical School
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing DMAC and CMAC in people with Obesity, run by The University of Texas Health Science Center, Houston at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 May 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Yes. Results are posted in the registry (first posted 26 May 2014). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time for Intubation (time frame: 90 seconds). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2014.